NVO 240809 128.00P (NVO240809P128000) Stock Options, News & Quotes

0.03
-0.95-96.94%

15min DelayClose Aug 9 16:00 ET

0.16High0.02Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Kevin Travers

Aug 9 10:15

Columns Moovin Stonks | Friday Market Calm Before Storm After Turbulent Week

Good morning, traders. Happy Friday, it's nearly afternoon and a tropical storm is coming to Jersey city. The market is turbulent and trying to not fall after the S&P 500 hit its best day for the year on Thursday. Monday was the worst trading day for the S&P 500 in two years.
My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ climbed a further 7% Friday after a Thursday Q2 earnings beat, boo...

Herd on Wall Street: mooving news stories and updates!

Invest Long ✓

Aug 9 04:20

$Novo-Nordisk A/S (NVO.US)$ how does this guy keeps going up when Eli Lilly was the one beating earnings.

BullnBearTrading

Aug 8 21:08

Market Overview

U.S. jobs data eased recession fears, and the continued decline of the yen also suppressed volatility caused by the unwinding of carry trades.
As a result, U.S. stocks opened higher and collectively closed near their daily highs. $S&P 500 Index (.SPX.US)$rose more than 2%, marking its biggest gain since November 2022, $Nasdaq Composite Index (.IXIC.US)$gained nearly 2.9%, $Dow Jones Industrial Average (.DJI.US)$surged over 680 points, $Russell 2000 Index (.RUT.US)$ climbed 2.4%, the Chinese Con...

Markets rally as recession fears ease: Take action or stay patient?

Foodie Investor

Aug 8 07:35

$NVIDIA (NVDA.US)$ niceee jobless claims much lower than estimates!! 🚀🚀 $Alphabet-C (GOOG.US)$ $Taiwan Semiconductor (TSM.US)$ $Eli Lilly and Co (LLY.US)$ $Novo-Nordisk A/S (NVO.US)$

Analysts Notebook

Aug 8 04:02

Columns Novo Nordisk Drops on Q2 Earnings and Sales Miss Despite Raised Outlook

$Novo-Nordisk A/S (NVO.US)$ shares tumbled 8.4% on Wednesday after the pharmaceutical giant announced disappointing second-quarter results for 2024. The company's flagship drugs, Ozempic and Wegovy, both reported significant sales increases but fell short of analysts' expectations. Ozempic, used for treating type 2 diabetes, saw a 30% rise in sales to $4.26 billion, below the anticipated $4.38 billion. Wegovy, aimed at obesity...